Worth reading
39Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Neutral
Direction inferred from the company’s description.Scale
551
百万円（分割対象資産の見込み額）Wording
Conditional
How definitive the wording is.This transaction
This company splitCounterpartyGMOコイン株式会社
Disclosing companyGMO Financial Holdings,Inc.
TimelineThe spacing between the points is proportional to the actual number of days.
Consideration and expenses
Acquisition price対価の交付は行わないため、取得価額なし
Type of Consideration対価なし（株式の割当てその他対価の交付は行わない）
Impact on Business Performance
The impact on the Company's consolidated results is expected to be immaterial.
Procedures and assumptions
Conditions Precedent to Execution株主総会の決議は不要（両社とも株主総会の決議を経ずに行う）
Management structure after acquisition当社及びGMOコインの名称、所在地、事業内容、資本金、決算期は変更なし。GMOコインの代表者も変更なし。当社は2026年３月19日付で、高島秀行氏が代表執行役会長兼社長CEOに就任し、石村富隆氏が退任する予定。
| Item | Details |
|---|---|
| Transaction name | This company split |
| Counterparty name | GMOコイン株式会社 |
| Acquisition price | 対価の交付は行わないため、取得価額なし |
| Type of Consideration | 対価なし（株式の割当てその他対価の交付は行わない） |
| Number of shares acquired | Not applicable（株式の取得なし） |
| Voting rights ownership percentage | Before 100% (after not disclosed) |
| Impact on Business Performance | The impact on the Company's consolidated results is expected to be immaterial. |
| Date of board resolution | 4 February 2026 |
| Contract Date | 4 February 2026 |
| Execution Date / Effective Date | 1 April 2026 (scheduled) |
| Conditions Precedent to Execution | 株主総会の決議は不要（両社とも株主総会の決議を経ずに行う） |
| Management structure after acquisition | 当社及びGMOコインの名称、所在地、事業内容、資本金、決算期は変更なし。GMOコインの代表者も変更なし。当社は2026年３月19日付で、高島秀行氏が代表執行役会長兼社長CEOに就任し、石村富隆氏が退任する予定。 |
Items this document does not state (20)
Name of the Subject CompanyBusiness Description of the Subject CompanyLocation of the Subject CompanyCapital Stock of the Subject CompanyDate of Establishment of the Subject CompanyNet Sales of the Subject CompanyOperating Profit of the Subject CompanyNet Income of the Subject CompanyNet Assets of the Subject CompanyExpenses other than the acquisition priceMerger ratio/share exchange ratioTender offer priceMinimum number of shares to be purchasedTender offer periodFunding arrangementsGoodwill amountAmount of extraordinary income (loss)Valuation methodologyIndependent valuation institutionSpecial Committee
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.GMOコインの東京証券取引所への株式上場準備の一環として、組織体制及び事業運営等における独立性を確保するため。
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.